Summary of the payer’s published policy. Not a coverage determination — confirm with the payer before submitting.
Recorded changes
86,510 on record
Recorded policy changes, newest first| Recorded | Payer | Policy | Change |
|---|
| Aug 2, 2026 | Louisiana Blue | 00348 Angiotensin II Receptor Blockers and Angiotensin II Receptor Blocker Combination DrugsPayerPolicy · BCBSLA-00348-C1E68DAE3A | New policy |
|---|
| Aug 2, 2026 | Louisiana Blue | 00347 Angiotensin Converting Enzyme-Inhibitors and Angiotensin Converting Enzyme-Inhibitor Combination DrugsPayerPolicy · BCBSLA-00347-E5CE62B6C0 | New policy |
|---|
| Aug 2, 2026 | Louisiana Blue | 00003 Stool-based and Blood-based Colorectal Cancer Screening TestsPayerPolicy · BCBSLA-00003-11420A1CE3 | New policy |
|---|
| Aug 2, 2026 | Louisiana Blue | 00002 Amnioreduction and/or Fetoscopic Laser Therapy for Twin-Twin Transfusion Syndrome - Retired PolicyPayerPolicy · BCBSLA-00002-0A9CEB31F8 | New policy |
|---|
| Aug 2, 2026 | Louisiana Blue | 00001 Ambulatory Blood Pressure Monitoring - Retired PolicyPayerPolicy · BCBSLA-00001-A18C2754CF | New policy |
|---|
| Aug 2, 2026 | Louisiana Blue | 00126 Alternative Treatments of Benign Prostatic Hypertrophy - Retired PolicyPayerPolicy · BCBSLA-00126-0FF223E35D | New policy |
|---|
| Aug 2, 2026 | Louisiana Blue | 00092 Allogeneic Pancreas TransplantPayerPolicy · BCBSLA-00092-DA0511CB27 | New policy |
|---|
| Aug 2, 2026 | Louisiana Blue | 00055 Hematopoietic Cell Transplantation for Genetic Diseases and Aplastic AnemiasPayerPolicy · BCBSLA-00055-ECFEC594C9 | New policy |
|---|
| Aug 2, 2026 | Louisiana Blue | 00061 Allogeneic Hematopoietic Cell Transplantation for Myelodysplastic Syndromes and Myeloproliferative NeoplasmsPayerPolicy · BCBSLA-00061-D65CF7F900 | New policy |
|---|
| Aug 2, 2026 | Louisiana Blue | 00350 Allergy Tests of Uncertain Efficacy - Retired PolicyPayerPolicy · BCBSLA-00350-ED2A1F1A3E | New policy |
|---|
| Aug 2, 2026 | Louisiana Blue | 00448 alemtuzumab (Lemtrada)PayerPolicy · BCBSLA-00448-18173A2565 | New policy |
|---|
| Aug 2, 2026 | Louisiana Blue | 00203 alefacept (Amevive) for Plaque Psoriasis - Retired PolicyPayerPolicy · BCBSLA-00203-22D232D205 | New policy |
|---|
| Aug 2, 2026 | Louisiana Blue | 00215 Advanced Therapies for Pharmacological Treatment of Pulmonary HypertensionPayerPolicy · BCBSLA-00215-7EA6E3E29C | New policy |
|---|
| Aug 2, 2026 | Louisiana Blue | 00248 Adoptive ImmunotherapyPayerPolicy · BCBSLA-00248-BDDC22D83F | New policy |
|---|
| Aug 2, 2026 | Louisiana Blue | 00493 Adipose-Derived Stem Cells in Autologous Fat Grafting to the Breast - Retired PolicyPayerPolicy · BCBSLA-00493-32524399AC | New policy |
|---|
| Aug 2, 2026 | Louisiana Blue | 00225 adalimumab ProductsPayerPolicy · BCBSLA-00225-7D2D145FA1 | New policy |
|---|
| Aug 2, 2026 | Louisiana Blue | 00330 ActigraphyPayerPolicy · BCBSLA-00330-BB470F1EF3 | New policy |
|---|
| Aug 2, 2026 | Louisiana Blue | 00308 Acoustic Cardiography-Retired PolicyPayerPolicy · BCBSLA-00308-191A5D9FDA | New policy |
|---|
| Aug 2, 2026 | Louisiana Blue | 00214 abatacept (Orencia)PayerPolicy · BCBSLA-00214-40D0967655 | New policy |
|---|
| Aug 2, 2026 | Louisiana Blue | 00809 Germline and Somatic Biomarker Testing (Including Liquid Biopsy) for Targeted Treatment and Immunotherapy in Prostate Cancer- Retired PolicyPayerPolicy · BCBSLA-00809-20B6D04355 | New policy |
|---|
| Aug 2, 2026 | Louisiana Blue | 00810 Germline and Somatic Biomarker Testing (Including Liquid Biopsy) for Targeted Treatment and Immunotherapy in Ovarian Cancer- Retired PolicyPayerPolicy · BCBSLA-00810-A5C42AE95B | New policy |
|---|
| Aug 2, 2026 | Louisiana Blue | 00983 icotrokinra (Icotyde)PayerPolicy · BCBSLA-00983-0D0EB5E9E1 | New policy |
|---|
| Aug 2, 2026 | Louisiana Blue | 00982 copper histidinate (Zycubo)PayerPolicy · BCBSLA-00982-A458757FB9 | New policy |
|---|
| Aug 2, 2026 | Louisiana Blue | 00980 doxecitine and doxribtimine (Kygevvi)PayerPolicy · BCBSLA-00980-424A37A175 | New policy |
|---|
| Aug 2, 2026 | Louisiana Blue | 00975 Immersive Virtual Reality Therapy for Chronic Lower Back PainPayerPolicy · BCBSLA-00975-5F6A583C44 | New policy |
|---|
| Aug 2, 2026 | Louisiana Blue | 00974 Pivya (pivmecillinam)PayerPolicy · BCBSLA-00974-4285292C78 | New policy |
|---|
| Aug 2, 2026 | Louisiana Blue | 00973 tividenofusp alfa-eknm (Avlayah)PayerPolicy · BCBSLA-00973-6B7B821B32 | New policy |
|---|
| Aug 2, 2026 | Louisiana Blue | 00972 sibeprenlimab (Voyxact)PayerPolicy · BCBSLA-00972-1DC34F3750 | New policy |
|---|
| Aug 2, 2026 | Louisiana Blue | 00971 aficamten (Myqorzo)PayerPolicy · BCBSLA-00971-698C31E5E7 | New policy |
|---|
| Aug 2, 2026 | Louisiana Blue | 00969 Cardamyst (etripamil)PayerPolicy · BCBSLA-00969-9BACB7899B | New policy |
|---|
| Aug 2, 2026 | Louisiana Blue | 00968 donidalorsen (Dawnzera)PayerPolicy · BCBSLA-00968-F763CFC98D | New policy |
|---|
| Aug 2, 2026 | Louisiana Blue | 00967 sebetralstat (Ekterly)PayerPolicy · BCBSLA-00967-716B724244 | New policy |
|---|
| Aug 2, 2026 | Louisiana Blue | 00966 garadacimab (Andembry)PayerPolicy · BCBSLA-00966-4DF719124D | New policy |
|---|
| Aug 2, 2026 | Louisiana Blue | 00965 Tonmya (cyclobenzaprine sublingual tablet)PayerPolicy · BCBSLA-00965-4A61810058 | New policy |
|---|
| Aug 2, 2026 | Louisiana Blue | 00964 elamipretide (Forzinity)PayerPolicy · BCBSLA-00964-B473DABAFA | New policy |
|---|
| Aug 2, 2026 | Louisiana Blue | 00963 Blujepa (gepotidacin)PayerPolicy · BCBSLA-00963-918528768C | New policy |
|---|
| Aug 2, 2026 | Louisiana Blue | 00962 mitapivat (Aqvesme)PayerPolicy · BCBSLA-00962-977648352B | New policy |
|---|
| Aug 2, 2026 | Louisiana Blue | 00961 Surgical Treatment of Tarlov CystPayerPolicy · BCBSLA-00961-EDBBA02D1A | New policy |
|---|
| Aug 2, 2026 | Louisiana Blue | 00960 Wound Care SuppliesPayerPolicy · BCBSLA-00960-AA9FF67D18 | New policy |
|---|
| Aug 2, 2026 | Louisiana Blue | 00959 remibrutinib (Rhapsido)PayerPolicy · BCBSLA-00959-AA4578D98E | New policy |
|---|
| Aug 2, 2026 | Louisiana Blue | 00958 paltusotine (Palsonify)PayerPolicy · BCBSLA-00958-5FA9A34FA9 | New policy |
|---|
| Aug 2, 2026 | Louisiana Blue | 00957 Prostate Artery EmbolizationPayerPolicy · BCBSLA-00957-6E8C510CBA | New policy |
|---|
| Aug 2, 2026 | Louisiana Blue | 00956 Raldesy (trazodone oral solution)PayerPolicy · BCBSLA-00956-AF093EA7E3 | New policy |
|---|
| Aug 2, 2026 | Louisiana Blue | 00954 sulopenem etzadroxil and probenecid (Orlynvah)PayerPolicy · BCBSLA-00954-FB9AC88424 | New policy |
|---|
| Aug 2, 2026 | Louisiana Blue | 00953 rilzabrutinib (Wayrilz)PayerPolicy · BCBSLA-00953-5D20E28A23 | New policy |
|---|
| Aug 2, 2026 | Louisiana Blue | 00952 revakinagene taroretcel-lwey (Encelto)PayerPolicy · BCBSLA-00952-2176D16494 | New policy |
|---|
| Aug 2, 2026 | Louisiana Blue | 00951 brensocatib (Brinsupri)PayerPolicy · BCBSLA-00951-8A277845F1 | New policy |
|---|
| Aug 2, 2026 | Louisiana Blue | 00950 delgocitinib (Anzupgo)PayerPolicy · BCBSLA-00950-1423D9CB40 | New policy |
|---|
| Aug 2, 2026 | Louisiana Blue | 00949 Zelsuvmi (berdazimer)PayerPolicy · BCBSLA-00949-E8C5523AC4 | New policy |
|---|
| Aug 2, 2026 | Louisiana Blue | 00948 eladocagene exuparvovec-tneq (Kebilidi)PayerPolicy · BCBSLA-00948-F9045E559D | New policy |
|---|